These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16885009)

  • 1. Commentary on peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
    Mayer EA
    J Pain; 2006 Aug; 7(8):539-41; discussion 542-3. PubMed ID: 16885009
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome.
    Price DD; Zhou Q; Moshiree B; Robinson ME; Verne GN
    J Pain; 2006 Aug; 7(8):529-35. PubMed ID: 16885007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Intrathecal lidocaine administration risk-free in rats with neuropathic pain? Reply to [Effects of intrathecal lidocaine on hyperalgesia and allodynia following chronic constriction injury in rats. Eur J Pain 13 (2009) 130-137].
    Umbrain V; Smolders I; Poelaert J
    Eur J Pain; 2009 Sep; 13(8):890; author reply 891. PubMed ID: 19324578
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional connectivity of the default mode network and its association with pain networks in irritable bowel patients assessed via lidocaine treatment.
    Letzen JE; Craggs JG; Perlstein WM; Price DD; Robinson ME
    J Pain; 2013 Oct; 14(10):1077-87. PubMed ID: 23743257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrathecal lidocaine on hyperalgesia and allodynia following chronic constriction injury in rats.
    Tian J; Gu Y; Su D; Wu Y; Wang X
    Eur J Pain; 2009 Feb; 13(2):130-7. PubMed ID: 18486505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamics of indices of visceral sensitivity in patients with irritable bowel syndrome treated with spasmolytics].
    Makarchuk PA
    Eksp Klin Gastroenterol; 2007; (6):126-9. PubMed ID: 18418922
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiological mechanisms in chronic musculoskeletal pain (fibromyalgia): the role of central and peripheral sensitization and pain disinhibition.
    Nielsen LA; Henriksson KG
    Best Pract Res Clin Rheumatol; 2007 Jun; 21(3):465-80. PubMed ID: 17602994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients.
    Verne GN; Robinson ME; Vase L; Price DD
    Pain; 2003 Sep; 105(1-2):223-30. PubMed ID: 14499439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of chronic lithium on visceral hypersensitivity in a rat model of diarrhea-predominant irritable bowel syndrome: The role of nitric oxide pathway.
    Shamshiri H; Paragomi P; Paydar MJ; Moezi L; Bahadori M; Behfar B; Ardalan FA; Dehpour AR
    J Gastroenterol Hepatol; 2009 Apr; 24(4):672-80. PubMed ID: 19032458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered rectal perception in irritable bowel syndrome is associated with symptom severity.
    Posserud I; Syrous A; Lindström L; Tack J; Abrahamsson H; Simrén M
    Gastroenterology; 2007 Oct; 133(4):1113-23. PubMed ID: 17919487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central origin of secondary mechanical hyperalgesia.
    Klede M; Handwerker HO; Schmelz M
    J Neurophysiol; 2003 Jul; 90(1):353-9. PubMed ID: 12843313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritable bowel syndrome as a common precipitant of central sensitization.
    Verne GN; Price DD
    Curr Rheumatol Rep; 2002 Aug; 4(4):322-8. PubMed ID: 12126584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal and visceral hypersensitivity in irritable bowel syndrome patients with and without fibromyalgia.
    Moshiree B; Price DD; Robinson ME; Gaible R; Verne GN
    Clin J Pain; 2007 May; 23(4):323-30. PubMed ID: 17449993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha2delta ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome?
    Camilleri M
    Gut; 2007 Oct; 56(10):1337-8. PubMed ID: 17872564
    [No Abstract]   [Full Text] [Related]  

  • 15. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases.
    Ceuleers H; Van Spaendonk H; Hanning N; Heirbaut J; Lambeir AM; Joossens J; Augustyns K; De Man JG; De Meester I; De Winter BY
    World J Gastroenterol; 2016 Dec; 22(47):10275-10286. PubMed ID: 28058009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of postoperative pain and the analgesia].
    TotokiT ; Ogawa S
    Masui; 1999; 48 Suppl():S101-8. PubMed ID: 10785968
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
    Ohman L; Simrén M
    Dig Liver Dis; 2007 Mar; 39(3):201-15. PubMed ID: 17267314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High doses of topically applied lidocaine in a cancer patient.
    Wilhelm IR; Griessinger N; Koppert W; Sittl R; Likar R
    J Pain Symptom Manage; 2005 Sep; 30(3):203-4. PubMed ID: 16183001
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersensitivity: a complex marker for a complex disease.
    Bouin M
    J Pain; 2006 Aug; 7(8):536-8; discussion 542-3. PubMed ID: 16885008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.